Hennessey C, Keogh CE, Barboza M, Brust-Mascher I, Knotts TA, Sladek JA, Pusceddu MM, Stokes P, Rabasa G, Honeycutt M, Walsh O, Nichols R, Reardon C, Gareau MG.
Infect Immun. 2021 Aug 16;89(9):e0005921. doi: 10.1128/IAI.00059-21. Epub 2021 Aug 16.
PMID:33820817
Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients.
Olvera A, Carter H, Rajan A, Carlin LG, Yu X, Zeng XL, Shelburne S, Bhatti M, Blutt SE, Shroyer NF, Jenq R, Estes MK, Maresso A, Okhuysen PC.
Clin Infect Dis. 2021 May 18;72(10):e620-e629. doi: 10.1093/cid/ciaa1394.
PMID:32930708
The cell death response to enteropathogenic Escherichia coli infection.
Wong Fok Lung T, Pearson JS, Schuelein R, Hartland EL.
Cell Microbiol. 2014 Dec;16(12):1736-45. doi: 10.1111/cmi.12371. Epub 2014 Oct 30.
PMID:25266336
Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.